This Cathie Wood Stock Could Soar 140%, Wall Street Says. Is That Too Optimistic?
Ginkgo Bioworks (NYSE: DNA) sells something very original: the large-scale design and production of organisms. And thanks to its innovations, the company has increased revenue almost 800% over the past five years. But Ginkgo's share price hasn't kept up, tumbling more than 80% from its initial public offering (IPO) just two years ago.
This isn't bothering famous investor Cathie Wood or Wall Street, though. Wood, known for her investments in undervalued innovators, has been steadily buying up Ginkgo shares over the past year. And Wall Street says the stock's time to shine may be right around the corner, with a prediction for a 140% gain in the coming 12 months.
Is that too optimistic? Let's find out.
Source Fool.com
